Novel Technologies For the Detection of Clinically Relevant DNA Alterations in Circulating DNAThursday, 29 March 2018 at 08:00 Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com With the increasing interest in treatment assessment using circulating DNA, sensitive and multiplexed detection of tumor-derived alterations in blood are desirable. We provide novel mutation enrichment-based methods that (a) enable several orders of magnitude improvement of microsatellite instability or mutations than currently possible; (b) are highly multiplex-able; (c) reduce the cost of both sample preparation and re-sequencing. Application in circulating DNA from clinical cancer samples will be presented. |